Enhanced Recovery After Cesarean Section
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04816279 |
|
Recruitment Status :
Not yet recruiting
First Posted : March 25, 2021
Last Update Posted : March 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
- Measure compliance of the care of elective caesarean section with ERAS standards
- Measure the quality of recovery of women undergoing elective caesarean section
| Condition or disease |
|---|
| Cesarean Section Quality Of Care |
Caesarean section is one of most common surgeries worldwide and in Egypt. The Egyptian Demographic and Health Survey 2014 revealed a rising caesarean section rate .
Many of these procedures are elective allowing time for preparation of the patient for surgery.
Enhanced recovery after surgery (ERAS) is a multimodal, multi disciplinary, evidence based approach to surgical care with an ultimate goal to enhance recovery and improve maternal and neonatal outcome .
This is done through optimizing multiple aspects of patient care to enhance recovery and so accelerate (facilitate) earlier discharge (decrease length of stay, decrease opioids use and encourage breastfeeding) .
A comparative study in Egypt found ERAS to be effective in controlling perioperative gastrointestinal symptoms, pain control and encourages early ambulation with offering earlier resumption of intestinal motility, higher satisfaction and fewer days of admission .
The clinical audit is a tool for assessing the compliance of current practice with the standard of care. In an audit, both process of care compliance and outcome of care can be measured to highlight gaps that need to be addressed by the institution . Enhanced Recovery After Surgery society issued Guidelines for elective Cesarean Section care .
They include elements in preoperative, intraoperative and postoperative care. Compliance with each of these items was associated with improved maternal or neonatal outcome and a better recovery experience .
| Study Type : | Observational |
| Estimated Enrollment : | 120 participants |
| Observational Model: | Other |
| Time Perspective: | Prospective |
| Official Title: | Clinical Audit on the Quality of Care of Elective Caesarean Section |
| Estimated Study Start Date : | April 2021 |
| Estimated Primary Completion Date : | April 2022 |
| Estimated Study Completion Date : | October 2022 |
| Group/Cohort |
|---|
| First Audit cycle |
| Second Audit cycle |
- the percentage of compliance of care with ERAS society guidelines [ Time Frame: baseline ]compliance of routinely provided care with ERAS society guidelines
- Quality of recovery after elective caesarean section [ Time Frame: baseline ]better recovery experience with less length of stay at hospital
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | Female |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Women undergoing elective caesarean section in the study period
Exclusion Criteria:
-
Women who cannot apply ERAS protocol
- emergency caesarean section
- anticipated surgical difficulty e.g. placenta previa/accrete, tumors obstructing lower uterine segment
- Severe maternal disease
- severe intraoperative bleeding or visceral injuries necessitating modification of postoperative care
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04816279
| Contact: Youstina Th Adeeb, Resident | 01001736168 | nanatharwat45@gmail.com |
| Responsible Party: | Youstina Tharwat Adeeb, Dr, Assiut University |
| ClinicalTrials.gov Identifier: | NCT04816279 |
| Other Study ID Numbers: |
CAQOCACS |
| First Posted: | March 25, 2021 Key Record Dates |
| Last Update Posted: | March 25, 2021 |
| Last Verified: | March 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

